Table III.
IVF benchmarks in cycles following PRP treatment.
| Benchmark N (%) | ALL | Group 1 a | Group 2b |
|---|---|---|---|
| Patients treated with PRP | 80 | 54 | 26 |
| Patients with evidence of antral follicle response | 67 (83.8) | 45 (83.3) | 22 (84.6) |
| Patients with at least one attempted retrieval | 53 (66.3) | 41 (75.9) | 12 (46.2) |
| Patients producing at least 1 oocyte | 42 (52.5) | 34 (63.0) | 8 (30.8) |
| Patients with at least 1 embryo transfer | 22 (27.5) | 21 (39.0) | 1 (3.9) |
| Patients with live birth per PRP treatment | 2 (2.5) | 2 (3.7) | 0 (0) |
| Patients with live birth if >1 oocyte retrieved | 2 (4.7) | 2 (5.8) | 0 (0) |
a
Group 1—regular menstrual cycles; bGroup 2—irregular menstrual cycles or amenorrhea.
PRP, platelet rich plasma.